Atlas Trials

Study of the SG001 Injection for Patients With Relapsed or Metastatic Uterine Cervical Cancer

Clinical trial NCT04886700 · UNKNOWN

Trial details

NCT number
NCT04886700
Sponsor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Uterine Cervical Cancer
Start date
2021-07-31
Primary completion
2022-12-31
Enrollment
104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.